InvestorsObserver
×
News Home

Core Laboratories N.V. (CLB) Stock: How Does it Score on Fundamental Metrics?

Wednesday, June 23, 2021 02:59 PM | InvestorsObserver Analysts

Mentioned in this article

Core Laboratories N.V. (CLB) Stock: How Does it Score on Fundamental Metrics?

Core Laboratories N.V. (CLB) receives a strong valuation ranking of 87 from InvestorsObserver's data analysis. The proprietary ranking system focuses on the underlying health of a company through analysis of its stock price, earnings, and growth rate. CLB has a better value than 87% of stocks based on these valuation analytics. Investors primarily focused on buy-and-hold strategies will find the valuation ranking relevant to their goals when making investment decisions.

Valuation Rank - 87
CLB gets a 87 Valuation Rank today. Find out what this means to you and get the rest of the rankings on CLB!

Metrics Analysis

CLB's trailing-12-month Price to Earnings (PE) ratio of 104.5 puts it above the historical average of roughly 15. CLB is a poor value at its current trading price as investors are paying more than what its worth in relation to the company's earnings. CLB's trailing-12-month earnings per share (EPS) of 0.42 does not justify what it is currently trading at in the market. Trailing PE ratios, however, do not factor in a company's projected growth rate, resulting in some firms having high PE ratios due to high growth potentially enticing investors even if current earnings are low.

CLB currently has a 12-month-forward-PE-to-Growth (PEG) ratio of 1.23. The market is currently overvaluing CLB in relation to its projected growth due to the PEG ratio being above the fair market value of 1. CLB's PEG comes from its forward price to earnings ratio being divided by its growth rate. Because PEG ratios include more fundamentals of a company's overall health with additional focus on the future, they are one of the most used valuation metrics by analysts.

Summary

CLB' has a weak valuation at its current share price on account of a overvalued PEG ratio despite strong growth. CLB's PE and PEG are worse than the market average leading to a below average valuation score.

Click Here to get the full Stock Score Report on Core Laboratories N.V. (CLB) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App